====== UMK57 1μM R01 exp59 ======
==== Mechanism of Action ====
Potentiates kinesin-13 (MCAK), destabilizes kinetochore-MT attachment, suppresses chromosome mis-segregation
* **Class / Subclass 1:** Cell Cycle / Mitotic Inhibitor
* **Class / Subclass 2:** Organelle Function / Cytoskeletal Inhibitor
==== Technical Notes ====
* **PubChem Name:** %%5-(4-Methylphenyl)-4-pyrrolidinylthiopheno[2,3-d]pyrimidine%%
* **Synonyms:** N/A
* **CAS #:** 342595-74-8
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/693939|693939]]
* **IUPAC:** %%5-(4-methylphenyl)-4-pyrrolidin-1-ylthieno[2,3-d]pyrimidine%%
* **INCHI Name:** InChI=1S/C17H17N3S/c1-12-4-6-13(7-5-12)14-10-21-17-15(14)16(18-11-19-17)20-8-2-3-9-20/h4-7,10-11H,2-3,8-9H2,1H3
* **INCHI Key:** VOAWQTDHSSKEKA-UHFFFAOYSA-N
* **Molecular Weight:** 295.4
* **Canonical SMILES:** CC1=CC=C(C=C1)C2=CSC3=NC=NC(=C23)N4CCCC4
* **Isomeric SMILES:** N/A
* **Molecular Formula:** C17H17N3S
{{:chemogenomics:structures:chem-0039.svg?nolink}}
* **Supplier Name:** In house - University of Montreal - Chemistry Platform
* **Catalog #:** N/A
* **Lot #:** N/A
* **HRMS (ESI-TOF) m/z:** [M+H]+ Calcd for C17H18N3S 296.1216; found 296.1142
* **Platform ID:** UMK57
* **Min:** -2.8530; **Max:** 75.4945
{{:chemogenomics:dose_response:dr_159.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |0.3698 |
| IC30 |0.6436 |
| IC40 |1.0136 |
| IC50 |1.5379 |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 01
* **Dose**: 1µM
* **Days of incubation**: 8
* **Doublings**: 5.2
* **Numbers of reads**: 15049192
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|27/49|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/UMK57_1uM_Round-1_exp59.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp59.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:D:DLGAP5|DLGAP5]]|-3.66|<0.01|
|[[:human_genes:Y:YPEL5|YPEL5]]|-3.46|<0.01|
|[[:human_genes:A:ARID4B|ARID4B]]|-3.31|<0.01|
|[[:human_genes:W:WDR61|WDR61]]|-3.27|0.02|
|[[:human_genes:A:ASPM|ASPM]]|-3.17|0.03|
|[[:human_genes:P:PDS5B|PDS5B]]|-3.10|0.01|
|[[:human_genes:T:TRIP13|TRIP13]]|-3.09|0.01|
|[[:human_genes:B:BRD1|BRD1]]|-3.08|<0.01|
|[[:human_genes:R:RNF111|RNF111]]|-3.06|<0.01|
|[[:human_genes:G:GTSE1|GTSE1]]|-2.98|0.02|
|[[:human_genes:P:PCGF1|PCGF1]]|-2.96|0.01|
|[[:human_genes:I:IPO11|IPO11]]|-2.92|0.03|
|[[:human_genes:I:ITPK1|ITPK1]]|-2.86|0.03|
|[[:human_genes:C:CNOT2|CNOT2]]|-2.83|0.03|
|[[:human_genes:N:NELFE|NELFE]]|-2.76|0.03|
|[[:human_genes:U:UBE2H|UBE2H]]|-2.74|0.03|
|[[:human_genes:W:WDR26|WDR26]]|-2.74|0.05|
|[[:human_genes:Z:ZNF367|ZNF367]]|-2.70|0.03|
|[[:human_genes:R:RBM26|RBM26]]|-2.62|0.04|
|[[:human_genes:M:MSI2|MSI2]]|-2.60|0.03|
|[[:human_genes:N:NMRK2|NMRK2]]|-2.58|0.05|
|[[:human_genes:G:GAK|GAK]]|-2.56|0.03|
|[[:human_genes:T:TCF4|TCF4]]|-2.54|0.03|
|[[:human_genes:P:PPIL1|PPIL1]]|-2.54|0.10|
|[[:human_genes:I:IKZF2|IKZF2]]|-2.54|0.03|
|[[:human_genes:M:MAFF|MAFF]]|-2.53|0.19|
|[[:human_genes:C:CTTNBP2|CTTNBP2]]|-2.53|0.05|
|[[:human_genes:D:DNAJC9|DNAJC9]]|-2.51|0.04|
|[[:human_genes:C:CD2BP2|CD2BP2]]|-2.45|0.22|
|[[:human_genes:R:RING1|RING1]]|-2.44|0.05|
|[[:human_genes:T:TLE4|TLE4]]|2.82|0.03|
|[[:human_genes:C:CYB5R4|CYB5R4]]|2.83|<0.01|
|[[:human_genes:A:ATXN7L3|ATXN7L3]]|2.83|0.01|
|[[:human_genes:C:C21orf140|C21orf140]]|2.84|0.03|
|[[:human_genes:L:LDLR|LDLR]]|2.84|<0.01|
|[[:human_genes:C:CBX3|CBX3]]|2.87|<0.01|
|[[:human_genes:S:SP3|SP3]]|2.87|0.01|
|[[:human_genes:K:KHDRBS1|KHDRBS1]]|2.88|0.01|
|[[:human_genes:K:KIFC1|KIFC1]]|2.88|<0.01|
|[[:human_genes:P:PPP1R2|PPP1R2]]|2.94|<0.01|
|[[:human_genes:A:ARIH1|ARIH1]]|3.02|0.01|
|[[:human_genes:A:ATP1A1|ATP1A1]]|3.05|<0.01|
|[[:human_genes:P:PPP6R3|PPP6R3]]|3.05|<0.01|
|[[:human_genes:S:SLC25A51|SLC25A51]]|3.10|<0.01|
|[[:human_genes:S:SETDB1|SETDB1]]|3.14|<0.01|
|[[:human_genes:A:ATF7IP|ATF7IP]]|3.18|<0.01|
|[[:human_genes:P:PPP2R4|PPP2R4]]|3.37|<0.01|
|[[:human_genes:A:AMBRA1|AMBRA1]]|3.39|<0.01|
|[[:human_genes:K:KIF2A|KIF2A]]|3.41|<0.01|
|[[:human_genes:M:MAPRE1|MAPRE1]]|3.58|<0.01|
|[[:human_genes:I:ID3|ID3]]|3.59|<0.01|
|[[:human_genes:C:CCNF|CCNF]]|3.82|<0.01|
|[[:human_genes:T:TP53|TP53]]|3.86|<0.01|
|[[:human_genes:P:PPME1|PPME1]]|4.11|<0.01|
|[[:human_genes:T:TIPRL|TIPRL]]|4.15|<0.01|
|[[:human_genes:K:KIF2C|KIF2C]]|4.44|<0.01|
|[[:human_genes:A:ATAT1|ATAT1]]|5.14|<0.01|
|[[:human_genes:P:PPP2R1A|PPP2R1A]]|5.14|<0.01|
|[[:human_genes:L:LCMT1|LCMT1]]|5.73|<0.01|
|[[:human_genes:K:KIF18B|KIF18B]]|7.13|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|0.126||
|[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|0.07||
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|0.216||
|[[:results:exp460|BML-284 0.09μM R08 exp460]]|0.172||
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.14||
|[[:results:exp312|2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312]]|0.13||
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|0.12||
|[[:results:exp517|Quercetin 20μM R08 exp517]]|0.105||
|[[:results:exp67|BVD-523 15μM R02 exp67]]|0.098||
|[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|0.096||
|[[:results:exp215|Colchicine 0.009μM R05 exp215]]|0.085||
|[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|0.081||
|[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|0.08||
|[[:results:exp103|Taxol 0.004μM R03 exp103]]|0.078||
|[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|0.074||
|[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|0.074||
|[[:results:exp80|RO-3307 4.7μM R02 exp80]]|0.069||
|[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.06||
|[[:results:exp502|Milciclib 2μM R08 exp502]]|0.058||
|[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|0.058||
|[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|0.055||
|[[:results:exp78|Pterostilbene 16μM R02 exp78]]|0.054||
|[[:results:exp45|Docetaxel 0.002μM R01 exp45]]|0.054||
|[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|0.053||
|[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|0.053||
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|0.052||
|[[:results:exp290|LLY-283 2.6μM R06 exp290]]|0.051||
{{:chemogenomics:comparison_plots:exp59_vs_exp60.png?nolink |}}
{{:chemogenomics:comparison_plots:exp190_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp217_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp460_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp106_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp46_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp517_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp59_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp179_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp215_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp228_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp311_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp103_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp184_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp310_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp59_vs_exp80.png?nolink |}}
{{:chemogenomics:comparison_plots:exp500_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp502_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp175_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp329_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp59_vs_exp78.png?nolink |}}
{{:chemogenomics:comparison_plots:exp45_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp529_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp231_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp3_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp290_vs_exp59.png?nolink |}}
No GO term hits below threshold. (FDR <0.05)
^GO Term^Fold Change^Genes^
|microtubule plus-end|71.99|KIF18B,KIF2C,MAPRE1|
|regulation of phosphoprotein phosphatase activity|51.34|TIPRL,PTPA,PPP6R3,PPP1R2|
|kinesin complex|50.17|KIF18B,KIF2C,KIF2A,KIFC1|
|regulation of phosphatase activity|38.73|TIPRL,PTPA,PPP6R3,PPP1R2|
|regulation of protein dephosphorylation|38.33|TIPRL,AMBRA1,PTPA,PPP6R3,PPP1R2|
|microtubule motor activity|33.45|KIF18B,KIF2C,KIF2A,KIFC1|
|protein phosphatase regulator activity|32.85|PPP2R1A,PPME1,PTPA,PPP6R3,PPP1R2|
|phosphatase regulator activity|28.74|PPP2R1A,PPME1,PTPA,PPP6R3,PPP1R2|
|regulation of dephosphorylation|27.87|TIPRL,AMBRA1,PTPA,PPP6R3,PPP1R2|
|mitotic sister chromatid segregation|24.71|KIF18B,PPP2R1A,KIF2C,MAPRE1,KIF2A,KIFC1|
|sister chromatid segregation|24.00|KIF18B,PPP2R1A,KIF2C,MAPRE1,KIF2A,KIFC1|
|protein phosphatase binding|20.29|PPME1,TP53,AMBRA1,PTPA,PPP6R3|
|mitotic nuclear division|17.14|KIF18B,KIF2C,MAPRE1,KIF2A,KIFC1|
|nuclear chromosome segregation|15.33|KIF18B,PPP2R1A,KIF2C,MAPRE1,KIF2A,KIFC1|
|mitotic cell cycle process|12.94|KIF18B,LCMT1,PPP2R1A,KIF2C,PPME1,TP53,CCNF,MAPRE1,KIF2A,PTPA,KIFC1,KHDRBS1|
|mitotic cell cycle|11.11|KIF18B,LCMT1,PPP2R1A,KIF2C,PPME1,TP53,CCNF,MAPRE1,KIF2A,PTPA,KIFC1,KHDRBS1|
|spindle|9.35|KIF18B,ATAT1,KIF2C,MAPRE1,KIF2A,KIFC1,CBX3|
|microtubule cytoskeleton organization|8.24|KIF18B,PPP2R1A,ATAT1,KIF2C,MAPRE1,KIF2A,PTPA,KIFC1|
|cell cycle process|7.64|KIF18B,LCMT1,PPP2R1A,KIF2C,PPME1,TP53,CCNF,MAPRE1,KIF2A,PTPA,KIFC1,KHDRBS1|